AbbVie - Largest Companies by Marketcap, Revenue, Net Income and Employees
Top Corporates Hub
AbbVie
ABBV
|
NYSE
|
United States
33
-2
Rank
$295.34B
Market Cap
$56.33B
+$ 0.8B
+1.44%
Revenue
$3.71B
-$ 1.37B
-26.97%
Earnings
55K
+5K
+10%
Employees
About
AbbVie Inc. (ABBV)
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.
- Sector: Health Technology
- Industry: Pharmaceuticals: Major
- Headquarters:
Latest News
-
AbbVie Highlights New Long-Term Data Advancing Treatment Standards in Inflammatory Bowel Diseases (IBD) at 2026 Digestive Disease Week®
05.05.2026 -
Guggenheim Reiterates Buy on AbbVie, Maintains $249 Price Target
01.05.2026 -
Is AbbVie Inc. (ABBV) One of the Best Drug Stocks to Buy According to Analysts?
01.05.2026 -
Allergan Aesthetics Launches Philanthropic Effort in Recognition of Skin Cancer Awareness Month
30.04.2026 -
AbbVie Q1 Earnings Call Highlights
30.04.2026